Literature DB >> 17635077

Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients.

Jaroslav A Hubacek1, Silvie Bloudícková, Romana Bohuslavová, Petr Táborský, Vladimír Polakovic, Magdaléna Sazamová, Eva Svítilová, Jicí Vlasák, Iva Sojková, Miroslav Ryba, Petr Knetl, Martin Ullrych, Radim Drahozal, Veronika Pavuková, Beata Pavlíková, Drahomíra Fischlová, Magdaléna Mokrejsová, Hana Chmelícková, Eva Pauchová, Pavel Vyskocil, Zuzana Nýdlová, Jaroslav Kopenec, Petr Fixa, Jan Hajný, Petr Bubenícek, Petr Syrovátka, Jana Zahálková, Stanislav Surel, Zdenek Hobzek, Ales Hrubý, Jana Suchanová, Svetlana Vanková, Jana Brabcová, Ondrej Viklický.   

Abstract

BACKGROUND: Ghrelin is an endogenous hormone expressed predominantly in the stomach. Ghrelin controls growth hormone secretion and also affects the body's energy balance. We analyzed the association of ghrelin variants with body mass index (BMI), albumin as a marker of malnutrition and plasma lipids as risk factors for atherosclerosis in hemodialyzed patients, in whom malnutrition and accelerated atherosclerosis are common complications.
METHODS: Ghrelin variants Arg51>Gln and Leu72> Met were analyzed by PCR-RFLP in 210 hemodialyzed patients, prospectively followed up for 15 months. Changes in body mass index, triglycerides, total cholesterol and albumin over time (after 3, 6, 9, 12 and 15 months of dialysis) were analyzed in subgroups divided according to ghrelin genotypes.
RESULTS: Carriers of at least one of the Gln51 and Met72 alleles lost body weight more quickly than Arg51Arg/Leu72Leu homozygotes (p<0.01). Carriers of the Gln51 allele were at higher risk of developing high cholesterol levels (p<0.01).
CONCLUSIONS: Common ghrelin variants may have an effect on changes in biochemical and anthropometric parameters in hemodialyzed patients over time and could be used in the future to plan individualized therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635077     DOI: 10.1515/CCLM.2007.141

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  3 in total

1.  Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls.

Authors:  Jaroslav A Hubacek; Silvie Bloudickova; Ruzena Kubinova; Hynek Pikhart; Ondrej Viklicky; Martin Bobak
Journal:  Biochem Genet       Date:  2009-06-30       Impact factor: 1.890

2.  Ghrelin in diabetes and metabolic syndrome.

Authors:  Leena Pulkkinen; Olavi Ukkola; Marjukka Kolehmainen; Matti Uusitupa
Journal:  Int J Pept       Date:  2010-04-27

3.  Plasma ghrelin levels in association with left ventricular function and nutritional status in dialysis patients.

Authors:  Libin Xu; Lei Yu; Ning Chi; Wenhao Wang; Guoping Liu; Wei Shi
Journal:  Biomed Rep       Date:  2016-04-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.